Search / 12 results found

from
to
  • Updated

CAMBRIDGE, Mass., Jan. 11, 2022 /PRNewswire/ -- Totus Medicines, a drug discovery company using breakthrough chemical biology to make the entire human genome druggable, today announced that CEO and co-founder Neil Dhawan, Ph.D. will present at the 40th annual J.P. Morgan HealthCare Conference on Thursday, January 13, at 8:00am ET.

  • Updated

CAMBRIDGE, Mass., Dec. 9, 2021 /PRNewswire/ -- Totus Medicines, a drug discovery company using breakthrough chemical biology to make the entire human genome druggable, today unveiled its revolutionary drug program targeting PI3Kα, the most commonly mutated cancer oncogene. The company also announced a $40 million Series A funding round led by investors DCVC Bio and Northpond Ventures and supported by Camford Capital with original seed funding from Social Impact Capital. The Series A financing will be used to expand and scale Totus Medicines' proprietary drug discovery platform and advance the company's lead program into the clinic.

  • Updated

BOSTON and NEW YORK and BASEL, Switzerland, Nov. 9, 2021 /PRNewswire/ -- BRITE GmbH and BRITE Discovery, LLC (together, "BRITE"), an emerging leader in the global enterprise data discovery and privacy management software space, today announced that legal industry veteran Derrick Logan has joined the company as its new Chief Revenue Officer. In partnership with executive search firm TRU Staffing Partners, Logan was chosen as the ideal candidate to build, lead and grow a widely diverse sales team to drive revenue and shareholder value.